Correction: Myeloid-driven immunosuppression in head and neck cancer: single-cell ATAC/RNA and spatial transcriptomic perspectives.
1/5 보강
[This corrects the article DOI: 10.3389/fonc.2025.1693152.].
APA
Luo R, Yang J, et al. (2026). Correction: Myeloid-driven immunosuppression in head and neck cancer: single-cell ATAC/RNA and spatial transcriptomic perspectives.. Frontiers in oncology, 16, 1788227. https://doi.org/10.3389/fonc.2026.1788227
MLA
Luo R, et al.. "Correction: Myeloid-driven immunosuppression in head and neck cancer: single-cell ATAC/RNA and spatial transcriptomic perspectives.." Frontiers in oncology, vol. 16, 2026, pp. 1788227.
PMID
41869664 ↗
Abstract 한글 요약
[This corrects the article DOI: 10.3389/fonc.2025.1693152.].
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- RMzyme: regulations of RNA-modifying enzymes in humans.
- Insights on nivolumab-based immunotherapy and prognostic stratification in older patients with metastatic renal cell carcinoma.
- Clinicopathologic and Molecular Characterization of Colorectal Cancer in Patients Aged ≥80 years.
- Myeloid-driven immunosuppression in head and neck cancer: single-cell ATAC/RNA and spatial transcriptomic perspectives.
- CPZ promotes the proliferation of gastric cancer by activating the Wnt pathway through binding with DVL2.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
- Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy.
- Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer.
- CEBPB-high dormant tumor cells drive immune evasion via S100A8 orchestrated tumor-associated macrophages reprogramming.
- Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma.
- Tumor-Derived CDC37 Inhibits Antigen Cross-Presentation in Dendritic Cells and Impairs Anti-Tumor Immunity in Breast Cancer.